Merck & Co

Pharmaceuticals

MRK

$ 128 (0.65)%

Share price

$ 325 bn

Market Cap

$ 354 bn

Enterprise Value

Carbon footprint

GHG emissions per $ 1 mln investment

0.08x the weighted average for S&P 500

FY2020

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Merck & Co reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 994 Kt (-83 /-7.7% y-o-y). At the same time, carbon intensity grew to 24 t (+0.9/+3.9% y-o-y).

Merck & Co's Scope 3 emissions increased to 7,103 Kt (+138/+2% y-o-y). The growth rate declined vs. the previous periods (CAGR +4.4% since 4Q'18).

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Date	Total CO2e emissions (market-based Scope 1 & 2) (Kt)	Scope 1	Scope 2	Scope 3	Revenue (USDm)	Carbon intensity (tons of CO2e) / (USDm)
2020Q4	994	738	255	7,103	41,518	24
2019Q4	1,077	799	318	6,966	46,840	23
2018Q4	1,198	800	399	6,240	42,294	28
2017Q4	1,279	806	463	6,586	40,122	32
2016Q4	1,398	862	537	7,975	39,807	35
2015Q4	1,459			5,586	39,498	37
2014Q4	1,532			5,760

Merck & Co

Carbon footprint

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Merck & Co's carbon footprint

Company environmental metrics